Navigation Links
CPA Acquires Renowned German Patent Research Specialist, SVPG
Date:10/8/2008

LONDON, October 8 /PRNewswire/ --

- Strengthens Expertise in Key Market and Industry Sectors, Including Pharmaceutical and Chemical

CPA, the world's top intellectual-property management specialist and a leading provider of outsourced legal support services, announced today that it has acquired renowned German patent research firm SVPG GmbH. Frankfurt-based SVPG, formerly part of Hoechst AG, has a proud history in patent research dating back more than 20 years and specialising in the pharmaceutical, chemical, life sciences, biotech, and engineering sectors.

The acquisition underlines CPA's commitment to become the leading player in the global patent research business by increasing its presence in key international markets and further strengthening its expertise in specialist industry sectors. CPA is already one of the largest patent researching entities in the world, with offices in the UK (London), Germany (Munich), the US (Alexandria, VA) and India (Noida), and more than 90 patent research specialists located across three continents.

Chris Veator, Executive Vice-President, CPA Legal Services, said: "We are continuing to expand our portfolio of patent lifecycle services, of which Patent Research is a critical component. Patent research is an area of strong growth in the outsourced legal services (http://www.cpaglobal.com/legal_process_outsourcing) industry, especially for CPA, and the acquisition of SVPG is a significant part of our growth strategy. It will make an important contribution towards our goal of becoming the recognised global leader in quality patent research for all our clients."

Randy Lacasse, Head of CPA's patent search business, said: "We're delighted to be bringing SVPG into our global patent research business. They are a highly respected firm with first rate patent research and technical analysis skills. The acquisition strengthens our presence and client base in the important German market, while further enhancing our expertise in key industry sectors such as pharmaceutical, chemical and life sciences, as well as our linguistic capabilities."

About SVPG

Formerly a business unit of German chemical and life sciences company Hoechst AG (now part of Sanofi Aventis), SVPG has a proud history in patent research dating back more than 20 years and specialising in the chemical, life sciences, pharmaceutical, biotech, and engineering sectors. SVPG counts amongst its clients many of the leading corporations and law firms in Germany.

For further information visit: http://www.svpg.de/en

About CPA

With clients in over 100 countries, CPA is a leading provider of outsourced legal support services and the world's top intellectual property (IP) management specialist. Founded in 1969, CPA provides lifecycle management services for intellectual property (http://www.cpaglobal.com) such as patent, design and trademark searching, watching, renewals, and portfolio strategy. CPA is also a leader in the growing market for outsourced contract management (http://www.cpaglobal.com/legal_process_outsourcing/contract_management) and litigation support services, helping law firms and corporations to realise value by managing risk, cost and capacity. CPA employs over 1,000 people in 16 offices in 8 countries.

For further information visit: http://www.cpaglobal.com

CPA and Patent Research

The value and critical nature of patents in business has become far more important and apparent in recent years, with patents underpinning a high proportion of corporate valuations through "intangible assets" and with increased emphasis on patent commercialisation, such as active patent portfolio strategy management, licensing, and divesting non-core assets. As a result, maintenance of existing portfolios, applications for new patents (http://www.cpaglobal.com/patents) and the rise of patent litigation are increasingly complicated, time consuming and costly. Patent research is a fundamental step in the process of filing patent applications, managing a patent portfolio and supporting patent litigation, which make it a key driver behind the Intellectual Property strategy (http://www.cpaglobal.com/ip-review-online/ip-strategy) of many businesses today. Now in its 15th year of patent research, CPA has conducted over 25,000 patent search projects and is one of the largest patent researching entities in the world, with more than 100 patent research specialists located across three continents able to consistently deliver high quality patent searches (http://www.cpaglobal.com/patents/research), quickly and methodically. CPA provides a full range of patent research services including Patentability/Novelty searches in support of new inventions, Freedom to Operate searches in connection with new product launches, advanced Patent Landscaping to assist strategic patent portfolio management ( http://www.cpaglobal.com/trademarks) and Validity or Clearance/Infringement searches related to patent litigation.

For further information visit: http://www.cpaglobal.com/patents

Related links:

http://www.cpaglobal.com

http://www.cpaglobal.com/patents/research

http://www.cpaglobal.com/patents

http://www.cpaglobal.com/legal_process_outsourcing

http://www.cpaglobal.com/trademarks

http://www.cpaglobal.com/legal_process_outsourcing/contract_management

http://www.cpaglobal.com/ip-review-online/ip-strategy

Media Contacts

UK

Steve Clark

CPA

+44(0)1784-224-351

sclark@cpaglobal.com

Kate Miller

Brunswick Group

+44(0)20-7404-5959

cpauk@brunswickgroup.com

USA

Julie Mandell

CPA

+1-571-227-7025

jmandell@cpaglobal.com

Justin Dini

Brunswick Group

+1-212-333-3810

cpaUS@brunswickgroup.com


'/>"/>
SOURCE CPA
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Circassia Acquires North American and Japanese Rights to Dopexamine
2. Advanced Instruments Acquires D & F Control Systems Inc.
3. Milestone Scientific Acquires Additional Patent Rights for Painless Injections and Resolves Related Litigations
4. MediCult Acquires US-Based MidAtlantic Diagnostics to Further Strengthen ART Presence
5. Arisyn Therapeutics Inc. Acquires Highly Novel Portfolio of Therapeutic Small Molecules for Infectious Disease and Cancer
6. Safecor Health Acquires Unit-Dose Pharmaceutical Leader RSC
7. Duff & Phelps Acquires Lumin Expert Group To Build Global Intellectual Property Practice
8. Kowa Company, Ltd. Acquires ProEthic Pharmaceuticals, Inc.
9. BioEnergy International, LLC Acquires Assets of OmniGene Bioproducts, Inc.
10. MacroGenics Acquires Raven Biotechnologies
11. Warburg Pincus Acquires 5.4% of WuXi PharmaTechs Outstanding Ordinary Shares from United Overseas Bank
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Feb. 24, 2017 Symic Bio, ... developing a new category of therapeutics, announced today the ... SB-030 in peripheral artery disease. The trial will evaluate ... single-use therapeutic, in the reduction of restenosis following angioplasty. ... critical development milestone for SB-030," said Nathan Bachtell ...
(Date:2/24/2017)... -- China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or ... China, today announced its financial results for the fourth quarter ... 2016 Financial Highlights Total sales in ... terms, or increased by 13.6% in USD terms to $77.6 ... Gross profit increased by 13.3% to $46.8 ...
(Date:2/23/2017)... -- Financial Highlights ... unaudited)Three Months Ended December 31,Twelve Months Ended December 31,20162015% ... $           300$   ... Product Revenue 3539(10)%9498(4)%Kuvan Net Product ... 756025%297303(2)%Vimizim Net Product Revenue ...
(Date:2/23/2017)... , Feb. 23, 2017  In Atlanta, it seems everyone ... and culture intertwine to create an expressive and dynamic community ... this energy and contribute to it. With ... Hair Fairies seeks to carry on that tradition with ... Atlanta salon is the newest of 13 ...
Breaking Biology Technology:
(Date:2/21/2017)... -- Der weltweite Biobanking-Sektor wird bis zum ... mit mehr als 50 Vertretern aus verschiedenen Branchen wurde aber ... diese Prognose zu realisieren. ... Zu den Schwierigkeiten für ... für die Biobank, die Implementierung Zeit sparender Technologien, ein ...
(Date:2/13/2017)... Former 9/11 Commission border counsel and Special Counsel to ... of Identity Strategy Partners, LLP, today releases the following ... Protecting the Nation From Foreign Terrorist Entry Into the ... Trump,s ,Travel Ban, Executive Order gains more notoriety and ... ban, it is important that our national discourse regain ...
(Date:2/8/2017)... Inc. (NASDAQ: AWRE ), a leading supplier of ... quarter and year ended December 31, 2016. ... compared to $6.9 million in the same quarter last year. ... million compared to $2.6 million in the fourth quarter of ... $0.5 million, or $0.02 per diluted share, which compares to ...
Breaking Biology News(10 mins):